New Onset Atrial Fibrillation Clinical Trial
Official title:
Anticoagulant and Antiarrhythmic Management Based on Continuous Rhythm Monitoring and Cardiac Imaging in Patients at Low Risk for Cardiovascular Events Following Direct Current Cardioversion for New Onset Atrial Fibrillation
This pilot study aims to assess the feasibility and safety of using an ILR to identify the incidence of recurrent AF after an episode of newly diagnosed AF. The study further aims to assess the risk of AF recurrence in this low risk population based on left atrial and left atrial appendage anatomic and functional indices in addition to the standardized clinical CHA2DS2-Vasc score.
There is a significant incidence of recurrent AF following initial diagnosis of AF.
Inclusion of left atrial (LA) and left atrial appendage (LAA) abnormalities together with
risk prediction of CVA using CHA2DS2-Vasc score will identify patients at low or high risk
for adverse cardiovascular events in patients with manifest and silent AF.
Patients requiring cardioversion have higher risk of recurrent AF in follow up.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04092621 -
Rapid Atrial Fibrillation Treatment Strategy
|
Phase 4 | |
Recruiting |
NCT05169866 -
Nifekalant Versus Amiodarone in New-Onset Atrial Fibrillation After Cardiac Surgery
|
Phase 3 | |
Terminated |
NCT02668432 -
Use of Amiodarone in Atrial Fibrillation Associated With Severe Sepsis or Septic Shock
|
Phase 4 | |
Completed |
NCT03977883 -
Management of Paroxystic Atrial Fibrillation in French Intensive Care Units
|
||
Completed |
NCT05511649 -
New-Onset Atrial Fibrillation Complicating Acute Myocardial Infarction in China
|
||
Recruiting |
NCT05229211 -
Tracking Atrial Fibrillation After Intensive Care Admission
|
||
Recruiting |
NCT05829317 -
Magnesium Prophylaxis for the Prevention of New-Onset Atrial Fibrillation in Critically Ill Patients
|
Phase 4 | |
Recruiting |
NCT04472299 -
Paravertebral Block to Reduce the Incidence of New Onset Atrial Fibrillation After Cardiac Surgery
|
Phase 4 |